RBP-7000
RB-US-09-0007
Phase 3 small_molecule completed
Quick answer
RBP-7000 for Schizophrenia is a Phase 3 program (small_molecule) at Indivior Pharmaceuticals with 5 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Schizophrenia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed